Who is popular today?

The United States will start to share up to 60 million doses of AstraZeneca’s coronavirus vaccine with other countries as they become available, White House senior Covid-19 adviser Andy Slavitt said on Monday.
“US to release 60 million AstraZeneca doses to other countries as they become available,” he wrote on Twitter.
The Associated Press earlier on Monday reported the doses would be shared in the coming months, following their clearance by the US Food and Drug Administration (FDA).
White House press secretary Jen Psaki confirmed the move.
The Biden administration in March said it would send roughly 4 million doses of the British drug maker’s vaccine to Canada and Mexico, and is under growing pressure now to expand sharing of its stockpile with India and other countries.
White House Covid-19 co-ordinator Jeff Zients told the AP that about 10 million doses of the AstraZeneca vaccine were ready to go and needed to pass a final FDA review, likely in the next several weeks.
He said about 50 million more doses are in “various stages of production” and could ship in May and June.
The US is looking at options to share the AstraZeneca doses because the vaccine has not yet been authorised for US use by the FDA and will not be needed by states during the next several months, he told the AP.
Supply commitments
An AstraZeneca spokeswoman could not comment on specifics of the arrangement, but said the doses were part of its supply commitments to the US government. “Decisions to send US supply to other countries are made by the US government,” she said.
The AP reported that the doses were made at the Emergent Biosolutions facility in Baltimore, Maryland, in the US, which came under harsh criticism for a long list of cleanliness and manufacturing problems found during an FDA inspection.
AstraZeneca is no longer making vaccine at that plant after a batch of Johnson & Johnson’s vaccine was ruined by contamination with ingredients from the AstraZeneca vaccine.
Johnson & Johnson is now overseeing production of its vaccine at the Emergent plant. – Reuters